Skip to main content
Erschienen in:

Open Access 01.12.2025 | Research

Person-centred care during treatment with nasal esketamine — a qualitative study

verfasst von: Lina Klysing, Ingrid Larsson, Katrin Häggström Westberg

Erschienen in: BMC Nursing | Ausgabe 1/2025

Abstract

Background

Patients suffering from treatment-resistant depression may be treated with nasal esketamine. The treatment requires administration in a healthcare facility and monitoring by a nurse. Existing research has mainly focused on the clinical effect of nasal esketamine, while less is known about patients’ experiences of treatment. A person-centred framework provides valuable insights into care and treatment. By using person-centredeness, the patient turns into a respected contributor in the delivery of care, enabling improved outcomes, better use of resources, reduced costs and increased satisfaction with care. Thus, the aim was to explore patients’ experiences of treatment with nasal esketamine utilizing the person-centred nursing framework by McCormack and McCance.

Methods

The study had a qualitative design with an abductive approach. Twenty patients with treatment-resistant depression who had received at least eight treatments of nasal esketamine were interviewed. A thematic analysis was conducted, based on the four constructs of PCC: prerequisites, care environment, person-centred process and expected outcomes. The analysis generated 11 subthemes, reflecting the contextuality of the PCC nursing framework.

Results

The results highlighted the importance of working in a person-centred manner to achieve increased patient satisfaction and treatment outcomes. Patients highlighted the importance of relationships with competent and engaged nurses and a supportive care environment for treatment outcomes. The physical care environment influenced patients’ well-being, and organizational aspects, such as continuity of staff, flexibility, and being allowed a private space, were also crucial during esketamine treatment. These aspects fostered feelings of security and contributed to achieving the desired outcome.

Conclusion

This study identified that key aspects of PCC; competent nurses and respect for the patient, comfort and personalization of the care environment, support and involvement are important in ensuring patient satisfaction, quality and ultimately the desired treatment outcomes in esketamine treatment. By adopting a person-centred approach, nurses can increase patient well-being and the quality of care in nasal esketamine treatment.

Clinical trial number

Not applicable.
Begleitmaterial
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12912-025-02943-y.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ESK
Nasal esketamine
PCC
Person-centred nursing framework
TRD
Treatment-resistant depression

Background

Depression is associated with higher mortality rates and affects well-being and quality of life in the same way as a major physical illness [1]. There are also major consequences of depression for the family and society, through increased healthcare costs and reduced productivity [2]. As approximately 30% of people with depression are considered treatment-resistant (TRD), in that they do not respond to currently available medications [3], the need for new and improved treatments is urgent. Nasal esketamine (ESK) (Spravato©) is a novel, fast-acting anti-depressant treatment for patients with TRD, approved in the European Union since 2019 [4]. ESK was originally developed from ketamine, traditionally used as a dissociative anaesthetic, and has a clinically proven positive effect on depressive symptoms [57]. It is an S-enantiomer of ketamine, targeting the glutamatergic system. The mode of action is through the non-competitive, non-selective antagonist effect on NMDA receptors, thought to increase neurotrophic signalling and dopaminergic transmission [8]. It is considered to be an efficacious and fast-acting anti-depressant treatment for patients with TRD, with a distinct safety profile and a different, intranasal method of administration [4, 8]. According to approved guidelines, ESK must be administered concomitantly with an SSRI/SNRI, prescribed by the treating psychiatrist after clinical judgment [4]. The induction phase is usually 4 weeks, with treatment initiating at 56 mg esketamine at the starting day, increased to 84 mg at subsequent visits. The first four weeks, treatment is administered twice weekly. Evidence of therapeutic benefit is evaluated after four weeks. If the patient shows signs of clinical improvement, treatment is continued weekly or bi-weekly, with the possibility of increasing dosing frequency should the patient relapse. Treatment is recommended to continue for at least six months after depressive symptoms improve.
Common side effects of ESK are visual and auditory perceptual changes, altered proprioception, sedation, disassociation, and occasionally ‘mystical’ experiences. Dizziness, nausea, anxiety, lethargy, hypoesthesia (loss of sensation), blood pressure elevation, vomiting, and feeling intoxicated are also common, but most side effects disappear within 90 min of administration [4, 7, 9]. ESK is administered in a healthcare facility and the patient is monitored for up to three hours after administration [7]. Thus, patients receiving ESK spend a substantial amount of time at the healthcare facility in the presence of a nurse, while being in a vulnerable state of mind, both related to the depression itself, but also because of the impact of the medication. The expert consensus statement on the practical recommendations for the management of TRD with ESK stresses that patient education is vital for compliance and adherence, as is the management of patient expectations of potential adverse events [9], but it seems only a limited number of studies have explored the patient experience of ESK [10].
Person-centred research shows a need to improve existing treatment options, by prioritizing patient well-being and collaboration with healthcare professionals, which is also the basis of the person-centred framework (PCC) [11, 12]. PCC is described as a mid-range healthcare theory based on evaluations of patient-centred care approaches to nursing and the patient’s values, needs, choices, and preferences in care planning and delivery [13]. PCC contains four constructs: prerequisites, care environment, person-centred processes, and outcomes. The goal of PCC is to reduce patient vulnerability through therapeutic engagement and to establish a collaborative care relationship between the patient and nurse, where both have equal power in decision making. The nurse-patient relationship is built on mutual trust, understanding, and knowledge sharing [13]. Prerequisites focus on the attributes of the nurse; being professionally competent, committed and being clear on personal beliefs and values. The care environment encompasses not only the organizational aspects of a smoothly functioning team, but also a flexible and supportive organization and the physical environment. Person-centred processes focus on delivering holistic care, with respect to the patient as a whole being, engaging in authentic, empathic and shared decision-making. The expected outcome reflects evaluation by a patient of a good care experience [14]. This framework of care has been shown to contribute to better outcomes for both patients and organizations, in the form of increased satisfaction with care and reduced costs [15, 16]. PCC also improves communication and the relationship between the nurse and the patient, which has a positive effect on adherence to treatment for depression, leading to better treatment outcomes [1719].
In ESK treatment, it is crucial to optimize outcomes, as these patients have a history of not responding to previous treatments. During treatment sessions, it is important to prioritize patients’ well-being, because they may have altered sensory experiences and dissociative side effects, which make them particularly vulnerable. This study contributes to increased knowledge of patients’ experiences of ESK treatment, through the lens of PCC.

Methods

The aim was to explore patients’ experiences of treatment with nasal esketamine utilizing the person-centred nursing framework by McCormack and McCance.

Study design and setting

This study had a qualitative design and employed semi-structured interviews, focusing on capturing and describing the experiences of patients receiving ESK treatment for TRD at a psychiatric out-patient clinic in Sweden. As ESK treatment is administered by a registered nurse, in this study, the term “nurse” signifies a registered nurse.

Participants and recruitment

A consecutive recruitment strategy was employed. All patients eligible for inclusion had been diagnosed with TRD by a psychiatrist and had received at least eight treatments of nasal esketamine, the minimum standard of treatment for induction and evaluation. They had no known aneurysmal vascular disease, hypertension or cardiovascular incident within the six weeks preceding the treatment start. The patient’s blood pressure had been controlled before initiation of the treatment. Information letters and consent forms with pre-paid envelopes were sent to 32 patients with TRD treated with ESK. After one week, patients were contacted by non-treating staff from the out-patient clinic via telephone and allowed to ask questions. In all, 22 patients agreed and provided written consent. The researcher contacted the patients who agreed to participate in the study by email or text message, to schedule an interview. Two patients who provided consent did not reply to messages or emails, resulting in 20 interviews conducted, with 11 women (55%) and 9 men (45%). The patients were aged 19–72, with an average age of 46. Fifteen patients had studied at university, four at secondary school, and one at primary school. Professions ranged across diverse fields, such as teaching, IT, and engineering. Sixteen patients were born in Sweden, while the remaining four were born abroad. Eleven lived with a partner, while nine lived alone or with their parents. The duration of the depression varied from between 1.5 and 42 years.

Data collection

The data were collected by way of individual, semi-structured interviews – a suitable method for exploring people’s thoughts and opinions. Such interviews involve the interviewer writing a guide with relevant questions about the subject under investigation, while allowing patients to express themselves in their own words, in order to provide a comprehensive account. An interview guide was developed by the research team, pilot-tested and subsequently used for all the interviews (see supplementary file A). The interviews were conducted between November 2023 and February 2024. LK conducted nineteen interviews, and one was done by KHW. Five interviews were held face-to-face at the psychiatric clinic, four via phone, and 11 interviews were done digitally, using ZOOM or Teams. Interview length ranged from 29 to 89 min (Median = 48), with a total interview length of 15 h and 9 min. All interviews were digitally recorded and transcribed verbatim.

Data analysis

The collected data was analysed using thematic analysis [20], with an abductive approach [21]. The analysis was done in steps (see Table 1), beginning with familiarization of the material, and open and inductive coding, performed by author LK. The codes were sorted into the various PCC constructs and compared within each construct. Sub-themes were identified and arranged on the basis of McCormack and McCance’s four constructs: prerequisites, care environment, person-centred processes, and expected outcomes [13]. The analysis was done in AtlasTi © (2002–2024 – ATLAS.ti Scientific Software Development GmbH, v8.7.1-2024-09-30). Coding was performed by one member of the research team (LK), with analysis and close collaboration between the research team. Two members of the research team were mental health credentialled nurses with several years of experience, whereas the third member had clinical experience primarily from the area of rheumatology, but extensive experience in methodological issues and nursing research within mental health. The background and expertise of the research team enhance the trustworthiness of this study.
Table 1
The analysis process
The aim was to explore patient experiences of treatment with nasal esketamine, utilizing a person-centred nursing framework
Step
Analysis method
Result
 
A
Inductive analysis
69 meaning units were identified and were sorted into 17 codes
 
B
Deductive analysis
Codes were sorted within the four constructs of PCC: prerequisites, care environment, person-centred processes, and expected outcomes
 
C
Inductive analysis
Codes within the constructs were compared and 11 subthemes emerged
 
D
Deductive
analysis
The subthemes were sorted within the four constructs of PCC: prerequisites, care environment, person-centred processes, and expected outcomes

Results

Through the patients’ narratives of treatment with ESK, the four constructs of PCC were identified: the prerequisites entailed receiving care from competent and engaged nurses who treated the patients with respect; the care environment needed to be comfortable, providing patients a private space, and the care had to adapt to individual needs; person-centred processes required that patients were made to feel as unique individuals, supported, and involved in their own care. The expected outcomes were feeling a sense of security and achieving the intended treatment outcomes (see Fig. 1).

Prerequisites

During ESK treatment, prerequisites for PCC were described in terms of the importance of meeting nurses who were competent and engaged. Patients also stressed the importance of being treated with respect.

Meeting competent nurses

Patients reported feeling protected and secure when they met competent nurses who could provide information and answer questions. They also valued feeling confident that nurses were doing what they could to meet their needs. “Yes, they are professionals. You can ask questions; they have a lot of experience. They know about psychiatry. And then they are just very warm people who listen and take you in and follow you, move on in the process as if you are not just a patient. You feel … you almost have a bit of a family feeling, in a way, that I have come in here and I immediately felt that these people will help me and take care of me. And that is extremely important in psychiatry. Especially when, after so many years, you are completely abandoned, and you get this kind of treatment”. (Participant no. 1)

Meeting engaged nurses

Patients described meeting engaged nurses who showed empathy, concern for the individual’s well-being, and a willingness to help make them feel secure and cared for. They also highlighted the value of nurses taking their time, showing patience, and demonstrating compassion in their care.“Yes, they do their best. There is a genuine desire to help. So it’s a good atmosphere.” (Participant no. 2).

Being treated with respect

To be treated with respect was a prerequisite for PCC. Patients felt seen and respected when they were listened to and taken seriously. Patients noted that a friendly reception and being greeted by name made them feel welcome and well-cared for, and that nurses with a calm, friendly, and gentle demeanour positively impacted their well-being.
“Yes, NN has a very pleasant manner. I liked her as a person and so it was already nice there, so she didn’t do anything special. She was herself or a nurse or whatever. And the same applies … well, if her name is NN or NN (name of nurse). I can’t remember anyone else who was there and helped in a soft, nice way.” (Participant no. 3).

Care environment

During treatment with ESK, patients described the importance of the care environment in PCC feeling comfortable, having a private space, and adapting care to individual needs.

Being comfortable

It was essential for the patients to be comfortable during the treatment. Reclining armchairs were used and most patients were satisfied with these; however, some wished they had the option to lie down on a bed. Some patients felt cold during treatment and appreciated receiving a blanket. Patients appreciated the homely environment at the clinic, as opposed to a traditional, sterile hospital environment. Patients also highlighted that they appreciated the presence of a therapy dog at the clinic, as it provided a sense of calm and did not demand that the patient be happy.
“I love animals, so that … But she’s so … When she’s in the same room, it’s like a calming effect on you, that there’s someone else coming to greet you and welcome you. It doesn’t matter if you’re crying or you’re looking a bit rubbish today, because you might not be at your best. So it doesn’t matter to her, because she always comes with her tail wagging. And then you make an effort, because it’s not her fault that I might not be at my best.” (Participant no. 4).
During treatment, some patients reported heightened senses, with the room’s sound and light significantly affecting their well-being. Patients noted an increase in their hearing sensitivity, with some preferring complete silence in the room, while others preferred to hear music playing. The music varied, but some patients found that specific types of music eased their experience and made their experience more comfortable. Patients preferred the lighting to be dimmed or turned off, although some patients were okay with daylight. The importance of being informed about their options and having their sound and light preferences addressed before treatment was emphasized.
“But an unreal experience, and the colours were enhanced, the curtains were not quite in place. My body was different, it was light and … a little dream-like state, and sounds were amplified. So I wanted to sit in a dark room, that was very important. No lights were allowed to be on.” (Participant no. 5).

Having a private space

Patients highlighted the significance of having a calm and private environment during treatment. They emphasized that it was crucial not to share treatment rooms with other patients, as they felt vulnerable and in need of solitude while under the influence of ESK. Some patients found it comforting to receive their treatment in the same room every time, while this did not matter for others.
“Do you think it’s important to come to the same room, or is it just as good to be in different ones? RESPONDENT: No, not if the whole environment, and I’m talking about the reception centre and the nurses there, was as safe as it was. It is possible that for some people, for some reason, they feel more secure in a certain room, but that was not the case for me; I felt secure in the premises in general and with the nurses.” (Participant no. 6).

Adapting care to individual needs

Patients emphasized that organizational factors, such as continuity of nurses with knowledge of each individual and flexible appointment times were important. Patients had disparate needs for supervision during their stay in the clinic after receiving ESK. Some always wanted the nurse to be present, while others wanted privacy. Some wanted varying levels of supervision from one time to the next. This study showed that supervision was adapted to the patient’s wishes and needs, rather than following a routine, which the patients appreciated and found positive for their experience.
“They usually asked do you want me to come in when you’re taking the next one, do you want me to stay, and stuff like that.” (Participant no. 7).

Person-centred processes

Patients receiving ESK emphasized the person-centred process in PCC with nurses supporting individuals, valuing their unique identity and involving them in decision making.

Being seen as a unique individual

Meeting the same nurse and building mutual trust was important for well-being and recovery. Patients also emphasized the importance of being seen as an individual by the nurse, rather than just a diagnosis or a number. This was done by being greeted by name and seeing that the nurse was interested in them. It was significant for their well-being to be heard and to be able to have conversations about their life in general, not just their mental health or treatment.
“Yes, but it has been great. Really, and my nurse, that’s probably the best thing that could happen I think, that I got her. So, it was a great relationship. And then you talk about all sorts of things. You get to know each other perhaps on a more superficial level, but still, it was cosy to have one and the same [nurse] and feel that she was always there.” (Participant no. 8).

Being supported

Patients described that the support of the nurse, which included both physical touch and comforting words, made it easier to cope with the side effects of ESK. The feeling of being supported by the nurse was facilitated by the fact that there was a reciprocal knowledge about one another and a progressive build-up of trust. As a result, patients did not always have to communicate their needs explicitly, as they were sometimes implicitly understood. Patients also expressed a feeling that the nurses were available and confident that they were there to help when needed. Some expressed that the support and relationship with the nurse felt as healing and important as ESK.
“I understand that there are people who drop out of treatment, because it’s very intense, and in … but in the right circumstances,… and I really felt that I had such a nice support, a good support. So that I felt I could… I could cope when it came… when it was very overwhelming.” (Participant no. 9).
A treatment that was vital for my life. And when I mean treatment, it’s … The esketamine in itself, well it has helped me a lot, but I don’t think I would have managed if I hadn’t had the support I have felt from the clinic. “ (Participant no. 11).

Being involved in one´s own care

Patients reported that they had the opportunity to be involved in decisions regarding their treatment and the arrangement of the room. This was achieved by the nurse asking questions such as “What do you think would be best for you?” Patients felt that their opinions were respected and considered. When patients were unable or unwilling to participate in care decisions, nurses sensitively took on a greater role in decision making. Patients also stated that they received enough information about the options, advantages, and disadvantages, so that they could make informed decisions. Being involved in the decision-making process was important for patients to feel secure and in control. The times patients were not allowed to be involved in the decision-making process, or their wishes were not granted had to do with factors related to patient safety, such as receiving treatment under supervision and not at home or receiving a dosage that was not in line with recommendations. Patients expressed the importance of nurses being aware and respectful, even when they were unable to partake in decisions. In some cases, the nurse made decisions on their behalf, but patients expressed a trust that nurses were acting in their best interest.
“It is probably as big as it can be without me taking over their role, that I can be involved and think and think and … They listen and if I am wrong, they explain. They don’t just say “No, but you don’t know this”, but they assume that I’m interested in it because it affects me and that I’ve read up on it and that … They listen and respect … Even when I’m wrong, they respect me. I guess that’s it, that I can have an influence on it. And it also feels more secure than if they just say “You’re going to try this for a month” and then you don’t know what it is at all.” (Participant no. 10).

Expected outcomes

Expected outcomes in PCC meant patients wanted to feel cared for and achieve their treatment goals.

Feeling a sense of security

Patients emphasized the importance of feeling safe and secure, to feel satisfied with their care experience. They had had previous experiences of not receiving adequate help, so it was important for them to feel cared for, listened to, and reassured that the nurse had the right skills and were doing what they could to help them. Patients reported a sense of reassurance when they found nurses to be available and attentive to their concerns.
“There and then I was taken care of by competent medical healthcare professionals. Doctors and nurses. I didn’t think I was competent to interfere with what they were doing, but I described what I was experiencing, and I was confident that they were doing the right thing.” (Participant no. 6).

Achieving desired treatment outcome

Patients in this study experienced a positive effect from treatment with ESK, feeling a sense of relief, improved coping with daily life, and an improved quality of life. The good relationship with the nurse and the care received during the treatment of ESK also positively impacted patients’ well-being. Some patients reported that it had a life-changing effect. Patients found it difficult to determine whether it was the medication or the nurse that made them feel better.
“Maybe half of it is NN and half of it is treatment. I can’t tell … percentage-wise. But if you understand, I think the whole thing has been … it has probably been extremely important. Because she has taken her time and so on and it was fantastic.” (Participant no. 11).

Discussion

This study aimed to explore patient experiences during treatment with ESK utilizing the person-centred nursing framework [13, 22]. Patient experiences generally matched the PCC framework. Prerequisites incorporated meeting competent, engaged nurses and being treated with respect; the care environment allowing flexibility of a supportive organization that was able to adapt to patients’ individual needs, and that patients were comfortable and had a private space; the person-centred process embodied that patients felt supported, valued as individuals and involved in their own care; and expected outcomes equated to feeling a sense of security, ultimately affecting treatment success.

Prerequisites

The findings demonstrate that patients perceived nurses at the psychiatric clinic as competent in psychiatric treatments and experienced in dealing with ESK. Research shows that meeting competent nurses who demonstrate caring abilities is fundamental to building patients’ trust [22], which in turn is a key factor in achieving positive health outcomes [23]. Nurses with knowledge and experience in treating individuals with mental health issues tend to have less stigmatized attitudes, which promotes a good patient-provider relationship [24]. The quality of the relationship between the nurse and the patient mainly depends on the nurse’s skills, such as self-awareness, communication ability, and the ability to show empathy [25]. Nurses must be skilled in communicating with patients as unique individuals, employ active listening, and ask questions [26]. Insufficient information about medication, inaccessible care, an unprofessional attitude, and a lack of professional counselling can be barriers to recovery from TRD [27]. This entails that nurses involved in treatment with ESK must have relevant knowledge of all aspects of the medication; pharmacokinetics, pharmacodynamics, potential side effects and expected treatment effect, to instil trust and promote recovery.
Patients in the current study also felt that nurses were engaged and had a genuine desire for their well-being, which made them feel more comfortable dealing with uncomfortable experiences associated with ESK. In PCC, nurses’ competence in communication and the ability to build relationships and recognize patients’ unique needs is essential to providing safe and secure care. It is also important for nurses to be diligent in their work and have a desire to provide the best care for the patient [14]. In the current study, patients identified that soft, friendly, kind, and calm personal qualities of nurses were associated with receiving good treatment. This conforms with the research on showing patients respect and providing good treatment, and the multifactorial nature of recovery according to patients’ beliefs [28]. Respectful treatment from nurses may be based on personal attributes such as caring, empathy, insightfulness, respectfulness, and competence [29]. However, personal attributes are also closely linked to organizational factors, such as support and flexibility, ultimately providing favourable conditions for good nursing care. The organization, or care environment, according to the PCC nursing framework, also needs to provide an opportunity for nurses to develop and safeguard their competence.
The importance of the physical care environment, also a part of the PCC construct, was stressed during treatment with ESK. Several patients appreciated that the clinic had a home-like environment, rather than a traditional hospital setting. An environment that instils calm and comfort promotes the patient’s well-being and health [13]. Patients wanted to be able to sit or lie comfortably while under the influence of ESK. It was important that the room was quiet and that they had the opportunity to sit alone, but using the same room for every treatment was not emphasized as necessary. This entails that clinics using ESK should enable patients to have access to private and quiet rooms with comfortable seating. The patients’ preferences for a private space need to be balanced with clinical supervision requirements for the safety of the patient during treatment. The rooms should be easily accessible for the nurses, with blood-pressure apparatus for monitoring possible hypertension and other side-effects such as vomiting and loss of consciousness. The rooms should also provide means for the patient to call for attention. The need for a private room might limit treatment of multiple patients simultaneously due to restrictions of space.
Some patients in the current study appreciated the flexibility in terms of arranging appointment times. According to Brand and Pollock [30], being flexible in the organization means adapting to, and meeting the patients’ specific needs, which also inspires trust. Thus, a supportive and flexible organization is essential as routines, power structures, attitudes, physical environment, and standardized procedures may be factors that otherwise limit the implementation of PCC [31]. Other studies show that time constraints and policies prevent nurses from interacting with patients in a meaningful way, and the focus is on the patient’s diagnosis rather than a holistic view of the patient and the care surrounding the patient. With no chance to take part in the patient’s experiences, values, and opinions, individual care and participation become unattainable [3234]. Developing a culture of care that values the relationship between nurses and patients can improve the quality of care and promote patient recovery from depression [28].
In the current study, patients noted that the ways in which nurses relate to, and treat patients, plays a significant role in patients’ well-being, and how patients perceive their treatment’s effectiveness. This is particularly true in PCC, where building a good relationship between nurses and patients is crucial. According to a study by Chambers et al. [35] and DeCou & Vidair [36], nurses must be non-judgemental, open-minded, good listeners, nice, calm, and accepting, and treat patients as whole humans and not cases. A good relationship is built when nurses commit to their patients and consider them to be equal partners in the decision-making process. In the current study, during the monitoring period, patients had varying preferences regarding frequency of supervision, and room environment, such as sound and light. Most patients felt that they had a say in how they wanted it and that the nurses adapted accordingly. This flexibility in supervision entails that nurses must have time assigned for each patient receiving treatment, as supervision will be more frequent at times and less frequent at other times. A few patients felt that they were unable to influence their care in some respects, such as wanting a dose or interval of treatment or wanting treatment at home, which went against the guidelines for the administration of ESK. Ensuring the patient understands the rationale behind guidelines, particularly from a safety perspective, is important for the relationship and ultimately, the treatment outcome. According to PCC, participation is a crucial aspect and involving the patients, and adapting to their needs, is essential for high quality in person-centred processes, and ultimately to achieving desired treatment outcomes. In the current study, patients described participation as being involved in decision-making processes regarding their care, where they were asked what they thought was best for them, and the nurse accommodated their preferences. They felt respected and valued when they could participate in their care, and that their opinions mattered. When patients are involved in their own care, they trust nurses more and are more likely to comply with treatment [28]. According to Sheldon [37], the ability of nurses to listen to the patient is an important aspect of involving the patient in decisions. Barriers to participation may arise when carers have a poor attitude, do not take the patient seriously, or are short of time [27]. In the current study, several patients highlighted the importance of having time to talk, not only about their illness, but about life in general. They appreciated it when nurses took the time to listen and made them feel seen as individuals. This is supported by Ekman et al. [11], who argue that the opportunity to talk about one’s well-being, life, and experiences is the basis for a good relationship between patients and nurses. It is likely that the substantial and recurring time spent together by nurse and patient during ESK contributes to high-quality, person-centred processes. Thus, ESK treatment and administration must be regarded as an encounter allowing interaction between patient and nurse, and not a quick and mechanical handing over of medication. This is also in line with the PCC processes, which emphasize the importance of the relationship between patient and nurse in establishing trust.
Patients stated that feeling secure during their treatment with ESK is critical, as the medication can cause unpleasant side effects. Thus, it is essential for patients to feel secure in their environment and with the nurse. Patients identified several factors that contributed to their sense of security, such as a comfortable and welcoming environment, seeing the same nurse at each visit, receiving care from professional and empathetic nurses, and having a say in their treatment. This aligns with Mollon’s [38] description of security as an emotional state that is impacted by memories and experiences. A peaceful and inviting care environment is crucial for patients’ sense of security, as both the physical and social environment impact their sense of security [39]. Building a robust relationship with a nurse involves continuously meeting the same nurse, which fosters trust and confidence, as long as the nurse is competent, responsive, and skilled in communication [40]. Continuity of care, such as seeing the same nurse at each visit, was perceived as fostering a sense of security and enabling individualized interactions. When the nurse knows the patient, it’s easier to pick up on non-verbal communication, such as mood, and facial expressions, and be able to identify any concerns and fears, thereby resulting in more effective care for patients [41, 42]. Today’s healthcare organizations struggle with providing continuous contact with the same healthcare professionals for patients, which potentially prolongs the effective recovery of TRD [43]. Clinics using ESK should prioritize staff continuity and strive to ensure that patients meet the same nurse to enhance the recovery process.
Patients in the current study reported positive outcomes from ESK, including reduced anxiety and improved ability to cope with daily activities, which helped them avoid negative thoughts and feelings. It is worth noting that some patients were uncertain whether their increased well-being was due to the medication per se or the nursing care and interactions with nurses. This underscores the importance of a person-centred approach to patients’ recovery.

Methodological considerations

As this study aims to describe patients’ experiences, a qualitative approach is advantageous, because it provides a nuanced picture of their experiences. The quality of qualitative studies is reviewed based on credibility, dependability, transferability, and confirmability [44]. A detailed description has been made based on the selection and analysis to enhance credibility. Twenty interviews were deemed sufficient for the purpose of the study, to discover similarities and variations in patients’ experiences. One limitation may be that most interviews were conducted digitally or over the phone, meaning that facial expressions and body language were missing. However, there are advantages to conducting interviews digitally, as it can be easier to share private information when there is a sense of anonymity and distance from the interviewer. Although two members of the research team had considerable experience as psychiatric nurses, the interviewer, LK, who conducted most of the interviews, had no prior experience of treating patients with ESK, nor any personal knowledge of the out-patient clinic – which enhances credibility. This study used an interview guide to ensure consistency in the questions asked and encourage participants to share their experiences freely, thus increasing dependability [45].
Diversity in terms of gender, age, and illness duration in this study encourages a breadth of experiences, which strengthens transferability [46, 47]. The study was conducted in a single clinic, which can affect transferability. Interviewing patients from multiple clinics with diverse environments, policies, and nurses would increase transferability [44]. Most patients responded well to treatment and had positive experiences with the care they received, expressing gratitude for the opportunity to try the treatment method. Therefore, it can be questioned whether critical perspectives, such as poor treatment outcomes or negative experiences, are underrepresented, and perhaps those who chose not to participate in the study opted out for this reason. TRD is a difficult condition to evaluate, as aspects such as compliance, other life events, the experience of previously failed treatments, the mood at interviews, etc., affect the patient’s experience of treatment and its effectiveness. Quotations are included in the Results section, to strengthen confirmability [46, 47].
To ensure trustworthiness, the study is reported in accordance with the Consolidated Criteria for Reporting Qualitative Research 32-item checklist [45].

Conclusion

This study highlights how patients experience treatment with ESK and how this aligns with the PCC nursing framework. The results indicate that nurse competence and commitment, in conjunction with a supportive and flexible organization, contribute to patients’ well-being. Besides inter-personal skills and attributes of the nurses, patients also highlighted the importance of a supportive care environment, comfortable seating arrangements, a private space and personalized care. In addition, patients valued being recognized as unique individuals, feeling supported throughout their treatment, and being involved in decisions related to their care. Ultimately, the expected outcomes of ESK treatment, in alignment with PCC, were to achieve the desired effect of the treatment and to feel a sense of security. Patients explicitly stated that they were unable to determine whether the positive outcomes they experienced related to the effect of the medication or the influence of the nursing care.
This study emphasizes the positive impact of a PCC approach on the well-being of patients undergoing treatment with ESK. The information may improve patient experience and well-being during nasal esketamine treatment in the future, as the results of this study can serve as a recommendation for improving the quality of care in treating patients with ESK. As PCC has numerous benefits for individuals and organisations, future research should focus on identifying the factors and barriers that prevent organisations from working with a person-centred approach.

Acknowledgements

We thank all the interviewees for their willingness to participate in the study and for sharing their experiences. We would also like to thank Caroline Karlsson for drafting the model and Lorna Campbell for language editing.

Declarations

This study was conducted according to the ethical guidelines of the Declaration of Helsinki [48]. Ethical approval was granted by the Swedish Ethical Review Authority (DNR 2023-5341-01). All the participants were given oral and written information about the aim of the study, that their participation was voluntary, and that they could withdraw from the study at any time without giving an explanation. Informed consent was obtained in written form from all participants.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Saarni SI, Harkanen T, Sintonen H, Suvisaari J, Koskinen S, Aromaa A, et al. The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Quality of life research: an international journal of quality of life aspects of treatment. Care Rehabilitation. 2006;15(8):1403–14. Saarni SI, Harkanen T, Sintonen H, Suvisaari J, Koskinen S, Aromaa A, et al. The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Quality of life research: an international journal of quality of life aspects of treatment. Care Rehabilitation. 2006;15(8):1403–14.
3.
Zurück zum Zitat Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–17.PubMedCrossRef Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–17.PubMedCrossRef
5.
Zurück zum Zitat Daly EJ, Singh JB, Fedgchin M, Cooper K, Lim P, Shelton RC, et al. Efficacy and safety of intranasal Esketamine adjunctive to oral antidepressant therapy in Treatment-Resistant depression: A randomized clinical trial. JAMA Psychiatry. 2018;75(2):139–48.PubMedCrossRef Daly EJ, Singh JB, Fedgchin M, Cooper K, Lim P, Shelton RC, et al. Efficacy and safety of intranasal Esketamine adjunctive to oral antidepressant therapy in Treatment-Resistant depression: A randomized clinical trial. JAMA Psychiatry. 2018;75(2):139–48.PubMedCrossRef
6.
Zurück zum Zitat Daly EJ, Turkoz I, Salvadore G, Fedgchin M, Ionescu DF, Starr HL, et al. The effect of Esketamine in patients with treatment-resistant depression with and without comorbid anxiety symptoms or disorder. Depress Anxiety. 2021;38(11):1120–30.PubMedPubMedCentralCrossRef Daly EJ, Turkoz I, Salvadore G, Fedgchin M, Ionescu DF, Starr HL, et al. The effect of Esketamine in patients with treatment-resistant depression with and without comorbid anxiety symptoms or disorder. Depress Anxiety. 2021;38(11):1120–30.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, et al. Efficacy and safety of flexibly dosed Esketamine nasal spray combined with a newly initiated oral antidepressant in Treatment-Resistant depression: A randomized Double-Blind Active-Controlled study. Am J Psychiatry. 2019;176(6):428–38.PubMedCrossRef Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, et al. Efficacy and safety of flexibly dosed Esketamine nasal spray combined with a newly initiated oral antidepressant in Treatment-Resistant depression: A randomized Double-Blind Active-Controlled study. Am J Psychiatry. 2019;176(6):428–38.PubMedCrossRef
8.
Zurück zum Zitat Kadriu B, Musazzi L, Henter ID, Graves M, Popoli M, Zarate CA. Jr. Glutamatergic neurotransmission: pathway to developing novel Rapid-Acting antidepressant treatments. Int J Neuropsychopharmacol. 2019;22(2):119–35.PubMedCrossRef Kadriu B, Musazzi L, Henter ID, Graves M, Popoli M, Zarate CA. Jr. Glutamatergic neurotransmission: pathway to developing novel Rapid-Acting antidepressant treatments. Int J Neuropsychopharmacol. 2019;22(2):119–35.PubMedCrossRef
9.
Zurück zum Zitat Kasper S, Cubala WJ, Fagiolini A, Ramos-Quiroga JA, Souery D, Young AH. Practical recommendations for the management of treatment-resistant depression with Esketamine nasal spray therapy: basic science, evidence-based knowledge and expert guidance. World J Biol Psychiatry: Official J World Federation Soc Biol Psychiatry. 2021;22(6):468–82.CrossRef Kasper S, Cubala WJ, Fagiolini A, Ramos-Quiroga JA, Souery D, Young AH. Practical recommendations for the management of treatment-resistant depression with Esketamine nasal spray therapy: basic science, evidence-based knowledge and expert guidance. World J Biol Psychiatry: Official J World Federation Soc Biol Psychiatry. 2021;22(6):468–82.CrossRef
10.
Zurück zum Zitat Starr HL, Abell J, Larish A, Lewis S, DeMuro C, Gogate J, et al. Self-reported review of the value of Esketamine in patients with treatment-resistant depression: Understanding the patient experience in the STRIVE study. Psychiat Res. 2020;293:113376.CrossRef Starr HL, Abell J, Larish A, Lewis S, DeMuro C, Gogate J, et al. Self-reported review of the value of Esketamine in patients with treatment-resistant depression: Understanding the patient experience in the STRIVE study. Psychiat Res. 2020;293:113376.CrossRef
11.
Zurück zum Zitat Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, et al. Person-centered care–ready for prime time. Eur J Cardiovasc Nurs. 2011;10(4):248–51.PubMedCrossRef Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, et al. Person-centered care–ready for prime time. Eur J Cardiovasc Nurs. 2011;10(4):248–51.PubMedCrossRef
12.
Zurück zum Zitat McCance T, McCormack B. The person-centred practice framework. In: McCormack B, McCance T, editors. Person-Centred practice in nursing and health care. Second ed. West Sussex, UK.: Wiley Blackwell;: Chichester; 2016. pp. 33–66. McCance T, McCormack B. The person-centred practice framework. In: McCormack B, McCance T, editors. Person-Centred practice in nursing and health care. Second ed. West Sussex, UK.: Wiley Blackwell;: Chichester; 2016. pp. 33–66.
13.
Zurück zum Zitat McCormack B, McCance TV. Development of a framework for person-centred nursing. J Adv Nurs. 2006;56(5):472–9.PubMedCrossRef McCormack B, McCance TV. Development of a framework for person-centred nursing. J Adv Nurs. 2006;56(5):472–9.PubMedCrossRef
14.
Zurück zum Zitat McCormack B, McCance T. The Person-Centred nursing framework. In: Dewing J, McCormack B, McCance T, editors. Person-centred nursing research: methodology, methods and outcomes. Cham, Switzerland: Springer; 2021. pp. 13–28.CrossRef McCormack B, McCance T. The Person-Centred nursing framework. In: Dewing J, McCormack B, McCance T, editors. Person-centred nursing research: methodology, methods and outcomes. Cham, Switzerland: Springer; 2021. pp. 13–28.CrossRef
15.
Zurück zum Zitat Berghout M, van Exel J, Leensvaart L, Cramm JM. Healthcare professionals’ views on patient-centered care in hospitals. BMC Health Serv Res. 2015;15:385.PubMedPubMedCentralCrossRef Berghout M, van Exel J, Leensvaart L, Cramm JM. Healthcare professionals’ views on patient-centered care in hospitals. BMC Health Serv Res. 2015;15:385.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Gluyas H. Patient-centred care: improving healthcare outcomes. Nurs Stand. 2015;30(4):50–7. quiz 9.PubMedCrossRef Gluyas H. Patient-centred care: improving healthcare outcomes. Nurs Stand. 2015;30(4):50–7. quiz 9.PubMedCrossRef
17.
Zurück zum Zitat Clever SL, Ford DE, Rubenstein LV, Rost KM, Meredith LS, Sherbourne CD, et al. Primary care patients’ involvement in Decision-Making is associated with improvement in depression. Med Care. 2006;44(5):398–405.PubMedCrossRef Clever SL, Ford DE, Rubenstein LV, Rost KM, Meredith LS, Sherbourne CD, et al. Primary care patients’ involvement in Decision-Making is associated with improvement in depression. Med Care. 2006;44(5):398–405.PubMedCrossRef
18.
Zurück zum Zitat Loh A, Leonhart R, Wills CE, Simon D, Härter M. The impact of patient participation on adherence and clinical outcome in primary care of depression. Patient Educ Couns. 2007;65(1):69–78.PubMedCrossRef Loh A, Leonhart R, Wills CE, Simon D, Härter M. The impact of patient participation on adherence and clinical outcome in primary care of depression. Patient Educ Couns. 2007;65(1):69–78.PubMedCrossRef
19.
Zurück zum Zitat McNaughton EC, Curran C, Granskie J, Opler M, Sarkey S, Mucha L, et al. Patient attitudes toward and goals for MDD treatment: a survey study. Patient Prefer Adherence. 2019;13:959–67.PubMedPubMedCentralCrossRef McNaughton EC, Curran C, Granskie J, Opler M, Sarkey S, Mucha L, et al. Patient attitudes toward and goals for MDD treatment: a survey study. Patient Prefer Adherence. 2019;13:959–67.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77–101.CrossRef
21.
Zurück zum Zitat Karlsen B, Hillestad TM, Dysvik E. Abductive reasoning in nursing: challenges and possibilities. Nurs Inq. 2021;28(1):e12374.PubMedCrossRef Karlsen B, Hillestad TM, Dysvik E. Abductive reasoning in nursing: challenges and possibilities. Nurs Inq. 2021;28(1):e12374.PubMedCrossRef
22.
Zurück zum Zitat Schaepe C, Ewers M. I need complete trust in nurses’– home mechanical ventilated patients’ perceptions of safety. Scand J Caring Sci. 2017;31(4):948–56.PubMedCrossRef Schaepe C, Ewers M. I need complete trust in nurses’– home mechanical ventilated patients’ perceptions of safety. Scand J Caring Sci. 2017;31(4):948–56.PubMedCrossRef
23.
Zurück zum Zitat Birkhäuer J, Gaab J, Kossowsky J, Hasler S, Krummenacher P, Werner C, et al. Trust in the health care professional and health outcome: A meta-analysis. PLoS ONE. 2017;12(2):e0170988.PubMedPubMedCentralCrossRef Birkhäuer J, Gaab J, Kossowsky J, Hasler S, Krummenacher P, Werner C, et al. Trust in the health care professional and health outcome: A meta-analysis. PLoS ONE. 2017;12(2):e0170988.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Eksteen H-C, Becker PJ, Lippi G. Stigmatization towards the mentally ill: perceptions of psychiatrists, pre-clinical and post-clinical rotation medical students. Int J Soc Psychiatry. 2017;63(8):782–91.PubMedCrossRef Eksteen H-C, Becker PJ, Lippi G. Stigmatization towards the mentally ill: perceptions of psychiatrists, pre-clinical and post-clinical rotation medical students. Int J Soc Psychiatry. 2017;63(8):782–91.PubMedCrossRef
25.
Zurück zum Zitat Leal-Costa C, Tirado Gonzalez S, Ramos-Morcillo AJ, Ruzafa-Martinez M, Diaz Agea JL. van-der Hofstadt Roman CJ. Communication skills and professional practice: does it increase Self-Efficacy in nurses? Front Psychol. 2020;11:1169.PubMedPubMedCentralCrossRef Leal-Costa C, Tirado Gonzalez S, Ramos-Morcillo AJ, Ruzafa-Martinez M, Diaz Agea JL. van-der Hofstadt Roman CJ. Communication skills and professional practice: does it increase Self-Efficacy in nurses? Front Psychol. 2020;11:1169.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Fraenkel L, McGraw S. What are the essential elements to enable patient participation in medical decision making? J Gen Intern Med. 2007;22(5):614–9.PubMedPubMedCentralCrossRef Fraenkel L, McGraw S. What are the essential elements to enable patient participation in medical decision making? J Gen Intern Med. 2007;22(5):614–9.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat van Grieken RA, Beune EJAJ, Kirkenier ACE, Koeter MWJ, van Zwieten MCB, Schene AH. Patients׳ perspectives on how treatment can impede their recovery from depression. J Affect Disord. 2014;167:153–9.PubMedCrossRef van Grieken RA, Beune EJAJ, Kirkenier ACE, Koeter MWJ, van Zwieten MCB, Schene AH. Patients׳ perspectives on how treatment can impede their recovery from depression. J Affect Disord. 2014;167:153–9.PubMedCrossRef
28.
Zurück zum Zitat Badger F, Nolan P. Attributing recovery from depression. Perceptions of people cared for in primary care. J Clin Nurs. 2007;16(3A):25–34.PubMedCrossRef Badger F, Nolan P. Attributing recovery from depression. Perceptions of people cared for in primary care. J Clin Nurs. 2007;16(3A):25–34.PubMedCrossRef
29.
Zurück zum Zitat Lakeman R. What is good mental health nursing? A survey of Irish nurses. Arch Psychiatr Nurs. 2012;26(3):225–31.PubMedCrossRef Lakeman R. What is good mental health nursing? A survey of Irish nurses. Arch Psychiatr Nurs. 2012;26(3):225–31.PubMedCrossRef
30.
Zurück zum Zitat Brand S, Pollock K. How is continuity of care experienced by people living with chronic kidney disease? J Clin Nurs. 2018;27(1–2):153–61.PubMedCrossRef Brand S, Pollock K. How is continuity of care experienced by people living with chronic kidney disease? J Clin Nurs. 2018;27(1–2):153–61.PubMedCrossRef
31.
Zurück zum Zitat Moore L, Britten N, Lydahl D, Naldemirci Ö, Elam M, Wolf A. Barriers and facilitators to the implementation of person-centred care in different healthcare contexts. Scand J Caring Sci. 2017;31(4):662–73.PubMedCrossRef Moore L, Britten N, Lydahl D, Naldemirci Ö, Elam M, Wolf A. Barriers and facilitators to the implementation of person-centred care in different healthcare contexts. Scand J Caring Sci. 2017;31(4):662–73.PubMedCrossRef
32.
Zurück zum Zitat Tobiano G, Bucknall T, Marshall A, Guinane J, Chaboyer W. Nurses’ views of patient participation in nursing care. J Adv Nurs. 2015;71(12):2741–52.PubMedCrossRef Tobiano G, Bucknall T, Marshall A, Guinane J, Chaboyer W. Nurses’ views of patient participation in nursing care. J Adv Nurs. 2015;71(12):2741–52.PubMedCrossRef
33.
Zurück zum Zitat Pelzang R. Time to learn: Understanding patient-centred care. Br J Nurs. 2010;19(14):912–7.PubMedCrossRef Pelzang R. Time to learn: Understanding patient-centred care. Br J Nurs. 2010;19(14):912–7.PubMedCrossRef
34.
Zurück zum Zitat Larsson IE, Sahlsten MJM, Segesten K, Plos KAE. Patients’ perceptions of barriers for participation in nursing care. Scand J Caring Sci. 2011;25(3):575–82.PubMedCrossRef Larsson IE, Sahlsten MJM, Segesten K, Plos KAE. Patients’ perceptions of barriers for participation in nursing care. Scand J Caring Sci. 2011;25(3):575–82.PubMedCrossRef
35.
Zurück zum Zitat Chambers E, Cook S, Thake A, Foster A, Shaw S, Hutten R, et al. The self-management of longer-term depression: learning from the patient, a qualitative study. BMC Psychiatry. 2015;15:172.PubMedPubMedCentralCrossRef Chambers E, Cook S, Thake A, Foster A, Shaw S, Hutten R, et al. The self-management of longer-term depression: learning from the patient, a qualitative study. BMC Psychiatry. 2015;15:172.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat DeCou SE, Vidair HB. What Low-Income, depressed mothers need from mental health care: overcoming treatment barriers from their perspective. J Child Fam Stud. 2017;26(8):2252–65.CrossRef DeCou SE, Vidair HB. What Low-Income, depressed mothers need from mental health care: overcoming treatment barriers from their perspective. J Child Fam Stud. 2017;26(8):2252–65.CrossRef
37.
Zurück zum Zitat Sheldon LK, Ellington L. Application of a model of social information processing to nursing theory: how nurses respond to patients. J Adv Nurs. 2008;64(4):388–98.PubMedCrossRef Sheldon LK, Ellington L. Application of a model of social information processing to nursing theory: how nurses respond to patients. J Adv Nurs. 2008;64(4):388–98.PubMedCrossRef
38.
Zurück zum Zitat Mollon D. Feeling safe during an inpatient hospitalization: a concept analysis. J Adv Nurs. 2014;70(8):1727–37.PubMedCrossRef Mollon D. Feeling safe during an inpatient hospitalization: a concept analysis. J Adv Nurs. 2014;70(8):1727–37.PubMedCrossRef
39.
Zurück zum Zitat Dahlberg K, Segesten K. Hälsa & Vårdande i Teori och praxis. Stockholm: Natur & Kultur; 2010. Dahlberg K, Segesten K. Hälsa & Vårdande i Teori och praxis. Stockholm: Natur & Kultur; 2010.
40.
Zurück zum Zitat Dinç L, Gastmans C. Trust in nurse–patient relationships: a literature review. Nurs Ethics. 2013;20(5):501–16.PubMedCrossRef Dinç L, Gastmans C. Trust in nurse–patient relationships: a literature review. Nurs Ethics. 2013;20(5):501–16.PubMedCrossRef
41.
Zurück zum Zitat Schultz K, Delva D, Kerr J. Emotional effects of continuity of care on family physicians and the therapeutic relationship. Can Fam Physician. 2012;58(2):178–85.PubMedPubMedCentral Schultz K, Delva D, Kerr J. Emotional effects of continuity of care on family physicians and the therapeutic relationship. Can Fam Physician. 2012;58(2):178–85.PubMedPubMedCentral
42.
Zurück zum Zitat Song HJ, Dennis S, Levesque J-F, Harris MF. What do consumers with chronic conditions expect from their interactions with general practitioners? A qualitative study of Australian consumer and provider perspectives. Health Expect. 2020;23(3):707–16.PubMedPubMedCentralCrossRef Song HJ, Dennis S, Levesque J-F, Harris MF. What do consumers with chronic conditions expect from their interactions with general practitioners? A qualitative study of Australian consumer and provider perspectives. Health Expect. 2020;23(3):707–16.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Nicaise P, Giacco D, Soltmann B, Pfennig A, Miglietta E, Lasalvia A, et al. Healthcare system performance in continuity of care for patients with severe mental illness: a comparison of five European countries. Health Policy. 2020;124(1):25–36.PubMedCrossRef Nicaise P, Giacco D, Soltmann B, Pfennig A, Miglietta E, Lasalvia A, et al. Healthcare system performance in continuity of care for patients with severe mental illness: a comparison of five European countries. Health Policy. 2020;124(1):25–36.PubMedCrossRef
44.
Zurück zum Zitat Polit D, Beck C. Essentials of nursing research. Appraising evidence for nursing practice, 9th ed. Philadelphia: Wolters Kluwer Health; 2018. Polit D, Beck C. Essentials of nursing research. Appraising evidence for nursing practice, 9th ed. Philadelphia: Wolters Kluwer Health; 2018.
45.
Zurück zum Zitat Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):329–57.CrossRef Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):329–57.CrossRef
46.
Zurück zum Zitat Lincoln YS, Guba EG. Naturalistic inquiry. Beverly Hills, CA: Sage; 1985.CrossRef Lincoln YS, Guba EG. Naturalistic inquiry. Beverly Hills, CA: Sage; 1985.CrossRef
47.
Zurück zum Zitat Adler RH. Trustworthiness in qualitative research. J Hum Lactation. 2022;38(4):598–602.CrossRef Adler RH. Trustworthiness in qualitative research. J Hum Lactation. 2022;38(4):598–602.CrossRef
48.
Zurück zum Zitat World Medical A. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.CrossRef World Medical A. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.CrossRef
Metadaten
Titel
Person-centred care during treatment with nasal esketamine — a qualitative study
verfasst von
Lina Klysing
Ingrid Larsson
Katrin Häggström Westberg
Publikationsdatum
01.12.2025
Verlag
BioMed Central
Erschienen in
BMC Nursing / Ausgabe 1/2025
Elektronische ISSN: 1472-6955
DOI
https://doi.org/10.1186/s12912-025-02943-y